Gavilimomab

From Self-sufficiency
Jump to: navigation, search
Gavilimomab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD147
Identifiers
CAS Number 244096-20-6
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Gavilimomab is a mouse monoclonal antibody (also known as ABX-CBL, developed by Abgenix[1]) is an immunosuppressive drug for the treatment of glucocorticoid resistant graft versus host disease. It binds to the antigen CD147.[1][2]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. 1.0 1.1 findarticles.com: Sangstat to Provide Clinical Development Update At JP Morgan H&Q Conference in San Francisco
  2. ClinicalTrials.gov